111 And Scrianen Forge Strategic Partnership To Enhance Drug Supply And Accessibility Across China
111 And Scrianen Forge Strategic Partnership To Enhance Drug Supply And Accessibility Across China
111和Scrianen達成戰略合作伙伴關係，促進藥品供應和可及性在中國範圍內提升
111, Inc. leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced that the Company has entered into a strategic direct supply partnership (the "Partnership") with Beijing Scrianen Pharmaceutical Co., Ltd. ("Scrianen"), a comprehensive pharmaceutical enterprise that integrates research and development, production and marketing.
111公司是一家領先的技術驅動醫療保健平台公司，致力於通過數字化賦能中國的上游和下游，重塑醫療保健行業的價值鏈。該公司宣佈與北京市裘安藥業股份有限公司（"裘安"）建立了戰略直接供應夥伴關係（"合作伙伴關係"），裘安是一家綜合性藥品企業，集研發、生產和營銷於一體。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。